Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
DUJON, Cécile
PROMETHEE, NCT06646471: PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies	Recruiting	4	500	Europe	Bio-bank repository, Quality of Life (QoL), G-Code	Groupe Francais De Pneumo-Cancerologie	Non Small Cell Lung Cancer, Lung Cancer	08/26	08/28
DIAL, NCT05255302 / 2021-006044-27: De-escalation Immunotherapy MAintenance Duration Trial for Stage IV Lung Cancer Patients with Disease Control After Chemo-immunotherapy Induction	Recruiting	2/3	1360	Europe	Pembrolizumab before randomization, Chemotherapy, Pemetrexed, Pembrolizumab after randomization	Intergroupe Francophone de Cancerologie Thoracique, IFCT	Metastatic NSCLC	01/25	06/29
ADAPTABLE, NCT05781308: Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients with Advanced NSCLC Progressing After Immunotherapy & Chemotherapy	Active, not recruiting	2	156	Europe	Paclitaxel, Bevacizumab, Avastin, Atezolizumab, Tecentriq	Intergroupe Francophone de Cancerologie Thoracique	Non Small Cell Lung Cancer	09/25	06/26
BIOEXALK, NCT05122806: Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC	Recruiting	N/A	100	Europe	RNAseq, DNA NGS	Groupe Francais De Pneumo-Cancerologie, Takeda	Non-small Cell Lung Cancer, ALK Gene Rearrangement Positive	06/27	06/27